A Critical Appraisal of Lipid Management in the Post-Statin Era: Comparison on Guidelines, Therapeutic Targets, and Screening in a Case-Based Framework of Lipid Management [0.03%]
他汀时代后期的血脂管理批判性评估：基于病例框架对比指南、治疗目标和筛查方法
Jared Spitz,Jaideep Patel,Anandita Agarwala et al.
Jared Spitz et al.
The role of low-density lipoprotein-cholesterol in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD) is well established. Lipid management remains the cornerstone of addressing ASCVD. In addition to statin therapy, there is...
Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans [0.03%]
钠-葡萄糖共转运体抑制可保护小鼠和人类在急性炎症时的载脂蛋白M
Carla Valenzuela Ripoll,Aynaz Lotfinaghsh,Zhen Guo et al.
Carla Valenzuela Ripoll et al.
Background: Sodium-glucose cotransporter inhibitors (SGLT2is) reduce inflammation and maintain vascular integrity. Apolipoprotein M (ApoM) is crucial for vascular integrity via sphingosine-1-phosphate (S1P) signaling and ...
Neighborhood Deprivation and Racial Disparities in Heart Failure Outcomes: A Counterfactual Approach [0.03%]
基于逆向因果推断方法分析社区剥夺感对心力衰竭结局种族差异的影响
Wenxi Huang,Yuru Zhu,Stephen E Kimmel et al.
Wenxi Huang et al.
Background: Heart failure (HF) is a major contributor to hospitalizations and mortality in the United States, with significant racial disparities in care access and clinical outcomes. Social determinants of health (SDoH) ...
Differential Selection of Obesity Treatments by Race/Ethnicity: Insights From the Veterans Affairs Healthcare System [0.03%]
种族/族裔差异选择肥胖症治疗方案：退伍军人事务医疗系统的启示
Rebecca L Tisdale,Tariku J Beyene,Wilson Tang et al.
Rebecca L Tisdale et al.
An HDL Proteomic Score Independently Predicts Incident Atherosclerotic Cardiovascular Disease [0.03%]
高密度脂蛋白蛋白质组评分可独立预测动脉粥样硬化性心血管疾病发病风险：新英格兰医学杂志老年心脏计划病例队列研究
Olle Melander,Anand Rohatgi,Judy Z Louie et al.
Olle Melander et al.
DASH Diet Adherence and Cardiovascular-Kidney Metabolic Syndrome Stages: National Health and Nutrition Examination Survey 2011-2020 [0.03%]
2011-2020年全国健康和营养调查中饮食临界值指数与心血管-肾脏代谢综合征分期的关系
Chelsea Akubo,India E Washington,Shanshan Song et al.
Chelsea Akubo et al.
Lifestyle Interventions in Cardiovascular-Kidney-Metabolic Syndrome JACC: Advances Expert Panel [0.03%]
心血管-肾脏-代谢综合征的生活方式干预《JACC》专家共识陈述
Izza Shahid,Jerrin Philip,Eleonora Avenatti et al.
Izza Shahid et al.
Cardiovascular-kidney-metabolic (CKM) syndrome impacts nearly all organ systems, with progressive dysfunction leading to morbidity and mortality. The high burden of CKM syndrome requires accessible, scalable, and low-cost interventions to p...
Impact of Pharmacist Telehealth Comanagement for Heart Failure: A Nonrandomized Controlled Study [0.03%]
药剂师远程医疗协同管理对心力衰竭的影响：一项非随机对照研究
D Steven Fox,Nadine Zawadski,Kimberly Buss et al.
D Steven Fox et al.
Background: Heart failure with reduced ejection fraction (HFrEF) imposes high morbidity and mortality burdens. Outcomes improve significantly with guideline-directed medical therapy (GDMT), but patients infrequently achie...
Automated Real-Time Percutaneous Coronary Intervention Risk Model Leveraging Electronic Health Records [0.03%]
基于电子健康记录的经皮冠状动脉介入治疗实时风险模型的自动化构建与验证
Mandeep Singh,Adelaide M Arruda-Olson,Bradley R Lewis et al.
Mandeep Singh et al.
Background: Automated individualized risk prediction tools linked to electronic health records (EHRs) are not available for patients undergoing percutaneous coronary interventions (PCIs). ...
Artificial Intelligence-Enabled Electrocardiograms: Do 15-Lead Studies Improve Model Performance? [0.03%]
人工智能心电图：15导联检查能否提高模型性能？
Joshua Mayourian,Sunil Ghelani,John K Triedman
Joshua Mayourian